These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 24138669)
1. Surveillance of pneumococcal serotype 1 carriage during an outbreak of serotype 1 invasive pneumococcal disease in central Australia 2010-2012. Lai JY; Cook H; Yip TW; Berthelsen J; Gourley S; Krause V; Smith H; Leach AJ; Smith-Vaughan H BMC Infect Dis; 2013 Sep; 13():409. PubMed ID: 24138669 [TBL] [Abstract][Full Text] [Related]
2. Age-specific cluster of cases of serotype 1 Streptococcus pneumoniae carriage in remote indigenous communities in Australia. Smith-Vaughan H; Marsh R; Mackenzie G; Fisher J; Morris PS; Hare K; McCallum G; Binks M; Murphy D; Lum G; Cook H; Krause V; Jacups S; Leach AJ Clin Vaccine Immunol; 2009 Feb; 16(2):218-21. PubMed ID: 19091995 [TBL] [Abstract][Full Text] [Related]
3. Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology. Adetifa IM; Antonio M; Okoromah CA; Ebruke C; Inem V; Nsekpong D; Bojang A; Adegbola RA PLoS One; 2012; 7(1):e30548. PubMed ID: 22291984 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease. Mackenzie GA; Leach AJ; Carapetis JR; Fisher J; Morris PS BMC Infect Dis; 2010 Oct; 10():304. PubMed ID: 20969800 [TBL] [Abstract][Full Text] [Related]
5. Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts' children to relatively low invasiveness. Yildirim I; Little BA; Finkelstein J; Lee G; Hanage WP; Shea K; Pelton SI; ; Vaccine; 2017 Jul; 35(32):4002-4009. PubMed ID: 28645717 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of an Australian serotype 1 Streptococcus pneumoniae outbreak. Staples M; Graham RM; Jennison AV; Ariotti L; Hicks V; Cook H; Krause V; Giele C; Smith HV Epidemiol Infect; 2015 Jan; 143(2):325-33. PubMed ID: 24666470 [TBL] [Abstract][Full Text] [Related]
7. Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. Influence of detection techniques on the results. Ercibengoa M; Arostegi N; Marimón JM; Alonso M; Pérez-Trallero E BMC Infect Dis; 2012 Mar; 12():69. PubMed ID: 22440017 [TBL] [Abstract][Full Text] [Related]
8. Carriage of multiple Streptococcus pneumoniae capsular types is frequent among children with invasive pneumococcal disease. Félix S; Henares D; Muñoz-Almagro C; Sá-Leão R Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2397-2401. PubMed ID: 33797644 [TBL] [Abstract][Full Text] [Related]
9. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290 [TBL] [Abstract][Full Text] [Related]
10. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275 [TBL] [Abstract][Full Text] [Related]
11. An outbreak of serotype-1 sequence type 306 invasive pneumococcal disease in an Australian Indigenous population. Cook HM; Giele CM; Jayasinghe SH; Wakefield A; Krause VL; Commun Dis Intell (2018); 2020 Sep; 44():. PubMed ID: 32988336 [TBL] [Abstract][Full Text] [Related]
12. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249 [TBL] [Abstract][Full Text] [Related]
13. Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data. Ojal J; Flasche S; Hammitt LL; Akech D; Kiti MC; Kamau T; Adetifa I; Nurhonen M; Scott JAG; Auranen K Vaccine; 2017 Aug; 35(35 Pt B):4561-4568. PubMed ID: 28729018 [TBL] [Abstract][Full Text] [Related]
14. Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary. Kovács E; Sahin-Tóth J; Tóthpál A; Kristóf K; van der Linden M; Tirczka T; Dobay O Vaccine; 2019 Jan; 37(1):99-108. PubMed ID: 30470639 [TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme. Wouters I; Van Heirstraeten L; Desmet S; Blaizot S; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H; Vaccine; 2018 Jan; 36(1):15-22. PubMed ID: 29180027 [TBL] [Abstract][Full Text] [Related]
16. Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy. Ansaldi F; de Florentiis D; Canepa P; Zancolli M; Martini M; Orsi A; Durando P; Icardi G Vaccine; 2012 Mar; 30(13):2288-94. PubMed ID: 22306795 [TBL] [Abstract][Full Text] [Related]
17. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Wroe PC; Lee GM; Finkelstein JA; Pelton SI; Hanage WP; Lipsitch M; Stevenson AE; Rifas-Shiman SL; Kleinman K; Dutta-Linn MM; Hinrichsen VL; Lakoma M; Huang SS Pediatr Infect Dis J; 2012 Mar; 31(3):249-54. PubMed ID: 22173142 [TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal pneumococcal carriage in healthy Turkish children after 13-valent conjugated pneumococcal vaccine implementation in the national immunization program. Kanık Yüksek S; Tezer H; Gülhan B; Özkaya Parlakay A; Güldemir D; Coskun-Ari FF; Bedir Demirdağ T; Kara Uzun A; Kızılgün M; Solmaz S; Kılıç S; Yalınay Çırak M; Baran Aksakal FN J Infect Public Health; 2020 Feb; 13(2):266-274. PubMed ID: 31818710 [TBL] [Abstract][Full Text] [Related]
19. Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska. Bruce MG; Singleton R; Bulkow L; Rudolph K; Zulz T; Gounder P; Hurlburt D; Bruden D; Hennessy T Vaccine; 2015 Sep; 33(38):4813-9. PubMed ID: 26247901 [TBL] [Abstract][Full Text] [Related]
20. Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia. Desai AP; Sharma D; Crispell EK; Baughman W; Thomas S; Tunali A; Sherwood L; Zmitrovich A; Jerris R; Satola SW; Beall B; Moore MR; Jain S; Farley MM Pediatr Infect Dis J; 2015 Nov; 34(11):1168-74. PubMed ID: 26226445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]